Top Markets
#1 Purr Purr +55.52%
#2 Pons Pons +55.24%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 StonkBroker StonkBroker +28.75%
#5 ApeX ApeX +27.06%
#6 Non-Playable Coin Non-Playable Coin +27.00%
#7 Kinetiq Kinetiq +24.56%
#8 Morpho Morpho +22.71%
#9 Pudgy Penguins Pudgy Penguins +21.56%
#10 OriginTrail OriginTrail +20.65%
Coin of the day
Purr Purr
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Rang în acțiuni #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Preț acțiune
$2.72
Ultima sincronizare: 2023-10-19
Capitalizare de piață
$111.47M
Schimbare (1 zi)
-0.73%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Talaris Therapeutics, Inc. (TALS)

Categorie

Healthcare
Venituri pentru Talaris Therapeutics, Inc. (TALS)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Talaris Therapeutics, Inc., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Talaris Therapeutics, Inc. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH